Evidence map›Paper›PMID 30988675›Full record

ArticleCellular & molecular biology letters2019

The role of miR-431-5p in regulating pulmonary surfactant expression in vitro.

Shujun Li, Zhongyi Sun, Tao Chen, Jingjing Pan, Yanqing Shen, Xiaoqing Chen, Xiaoyu Zhou, Rui Cheng, Yang Yang

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shujun Li *1Department of Pediatrics, Children's Hospital of Anhui Medical University, Hefei, China.
Zhongyi Sun *2Department of Pediatrics, The First Affliated Hospital of Nanjing Medical University, Nanjing, China.
Tao Chen3Department of Cardiothoracic Surgery, The First Affliated Hospital of Anhui Medical University, Hefei, China.
Jingjing Pan2Department of Pediatrics, The First Affliated Hospital of Nanjing Medical University, Nanjing, China.
Yanqing Shen4Department of Neonates, Children's Hospital of Nanjing Medical University, No 72, Guangzhou Road, Nanjing, 210008 China.
Xiaoqing Chen2Department of Pediatrics, The First Affliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaoyu Zhou4Department of Neonates, Children's Hospital of Nanjing Medical University, No 72, Guangzhou Road, Nanjing, 210008 China.
Rui Cheng4Department of Neonates, Children's Hospital of Nanjing Medical University, No 72, Guangzhou Road, Nanjing, 210008 China.
Yang Yang4Department of Neonates, Children's Hospital of Nanjing Medical University, No 72, Guangzhou Road, Nanjing, 210008 China.
Second Affiliated Hospital of Nanjing Medical University · CNNanjing Medical University · CNAnhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary surfactant is the complex mixture of lipid and protein that covers the alveolar surface. Pulmonary surfactant deficiency is one of the main causes of neonatal respiratory distress. Recent studies showed that miRNA plays an important role in lung development, but research into miR-431 regulation of pulmonary surfactant are sparse. In this study, we explored the regulatory role of miR-431-5p in the expression of pulmonary surfactant and identified its potential target gene, Smad4.

methodsThe bioinformatics tool TargetScan was used to predict the targets of miR-431. The expression of miR-431-5p was achieved via transfection of miR-431-5p mimics, an miR-431-5p inhibitor and corresponding negative control. The level of miR-431-5p was determined using quantitative real-time PCR. The CCK8 assay was conducted to confirm cell growth 12 h after transfection with miR-431-5p mimics, inhibitor or NC. Smad4 and surfactant-associated proteins in A549 were analyzed using western blot and quantitative real-time PCR.

resultsSmad4 was validated as a target of miR-431 in A549 cells. Overexpression of miR-431 accelerated A549 proliferation and inhibited A549 apoptosis. The mRNA and protein levels for the surfactant proteins (SP-A, SP-B, SP-C and SP-D) were found to be differentially expressed in A549 cells over- or under-expressing miR-431-5p.

conclusionOur results show that miR-431-5p is critical for pulmonary surfactant expression and that its regulation is closely related to the TGF-β/Smad4 pathway. These results will help us to study the pathophysiological mechanism of lung developmental diseases.

Indexed as

3' Untranslated RegionsA549 CellsApoptosisBase SequenceCell ProliferationHumansMicroRNAsPulmonary SurfactantsSmad4 Protein3' Untranslated RegionsMicroRNAsMIRN431 microRNA, humanPulmonary SurfactantsSmad4 ProteinSMAD4 protein, humanLung developmentmiR-431-5pPulmonary surfactantTGF-β/Smads pathway

Identifiers

PMID30988675
PMCPMC6446292
OpenAlexW2934497074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.